The DOI matches its Crossref record; 99 of the 99 references it cites were found in a registry or an index.
Molecular mechanism of action of metformin: old or new insights?
Open accessAbstract
Metformin is the first-line drug treatment for type 2 diabetes. Globally, over 100 million patients are prescribed this drug annually. Metformin was discovered before the era of target-based drug discovery and its molecular mechanism of action remains an area of vigorous diabetes research. An improvement in our understanding of metformin's molecular targets is likely to enable target-based identification of second-generation drugs with similar properties, a development that has been impossible up to now. The notion that 5' AMP-activated protein kinase (AMPK) mediates the anti-hyperglycaemic action of metformin has recently been challenged by genetic loss-of-function studies, thrusting the AMPK-independent effects of the drug into the spotlight for the first time in more than a decade. Key AMPK-independent effects of the drug include the mitochondrial actions that have been known for many years and which are still thought to be the primary site of action of metformin. Coupled with recent evidence of AMPK-independent effects on the counter-regulatory hormone glucagon, new paradigms of AMPK-independent drug action are beginning to take shape. In this review we summarise the recent research developments on the molecular action of metformin.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Metformin is an insulin-sensitizing drug, known to inhibit gluconeogenesis and lipogenesis (7)”
From Metformin and Combined Oral Contraceptive Pills in the Management of Polycystic Ovary Syndrome: A Systematic Review and Meta-analysis (2024) · cites this paper as [7]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Role of AMP-Activated Protein Kinase in Mechanism of Metformin Action
Zhou, G., Myers, R., Li, Y., Chen, Y., Shen, X., Fenyk-Melody, J., Wu, M., Ventre, J., Doebber, T., Fujii, N., et al. (2001) · Journal of Clinical Investigation · doi:10.1172/jci13505 · Cited by 5,652
AMPK: a nutrient and energy sensor that maintains energy homeostasis
Hardie, D. G., Ross, F. A., & Hawley, S. A. (2012) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3311 · Cited by 4,602
Inzucchi, S. E., Bergenstal, R. M., Buse, J. B., Diamant, M., Ferrannini, E., Nauck, M., Peters, A. L., Tsapas, A., Wender, R., & Matthews, D. R. (2012) · Diabetologia · doi:10.1007/s00125-012-2534-0 · Cited by 3,919
Watterson, K. R., Bestow, D., Gallagher, J. R., Hamilton, D. L., Ashford, F. B., Meakin, P. J., & Ashford, M. L. J. (2012) · Neurosignals · doi:10.1159/000334144 · Cited by 3,395
Kahn, B. B., Alquier, T., Carling, D., & Hardie, D. G. (2005) · Cell Metabolism · doi:10.1016/j.cmet.2004.12.003 · Cited by 2,799
The selectivity of protein kinase inhibitors: a further update
Bain, J., Plater, L., Elliott, M., Shpiro, N., Hastie, C. J., McLauchlan, H., Klevernic, I. V., Arthur, J. S. C., Alessi, D. R., & Cohen, P. (2007) · Biochemical Journal · doi:10.1042/bj20070797 · Cited by 2,522
Metformin and reduced risk of cancer in diabetic patients
Evans, J. M. M., Donnelly, L. A., Emslie-Smith, A. M., Alessi, D. R., & Morris, A. D. (2005) · BMJ · doi:10.1136/bmj.38415.708634.f7 · Cited by 2,388
OWEN, M. R., DORAN, E., & HALESTRAP, A. P. (2000) · Biochemical Journal · doi:10.1042/bj3480607 · Cited by 2,157
Flagged first, then by citations
Research works printed but not linked: 2
- Ray RK, Kauffman GB (1999) Metal and non-metal biguanide complexes. New Age International Publishers, New Delhi
- Kazda CM, Garhyan P, Kelly RP et al (2012) 12-week treatment with glucagon receptor antagonist LY2409021 significantly lowers HbA1c and is well tolerated in patients with type 2 diabetes mellitus. Diabetologia 55(Suppl 1):S51, Abstr. 112
Cited by
Sorted by citations
Items 401–479 of 479
Type 2 Diabetes Mellitus in Youth
Srinivasan, S., & Levitsky, L. L. (2018) · Springer eBooks · doi:10.1007/978-3-319-73782-9_32 · Cited by 1
Cantó, C. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-811752-1.00017-1 · Cited by 1
Diet as a therapeutic approach to diabetes management and pancreas regeneration
Villani, V., & Perin, L. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-814831-0.00015-4 · Cited by 1
Clavijo, A. ́. G., Maya, L. F. F., Muñoz-Loaiza, J. D., Perilla-Roa, D., Pérez-Moreno, E. J., Guzmán-Rojas, J. D. D., & Herrera-Cardona, J. E. (2020) · Revista de la Facultad de Medicina · doi:10.15446/revfacmed.v68n4.77325 · Cited by 1
Guevara-Vásquez, A. M., Florián, J. C., & Dávila-Castillo, J. H. (2021) · Journal of Herbmed Pharmacology · doi:10.34172/jhp.2021.42 · Cited by 1
Krikorian, A., & Calimag, A. P. P. (2022) · Springer eBooks · doi:10.1007/978-3-030-86020-2_21 · Cited by 1
Pharmacological treatment of equine endocrine diseases
McFarlane, D. (2014) · doi:10.1002/9781118845110.ch15 · Cited by 1
Mkhize, P. B. (2016) · DUT Open Scholar (Durban University of Technology) · doi:10.51415/10321/1557 · Cited by 1
The effect of metformin on absolute telomere length
Robb-Mackay, C. (2018) · Cited by 1
Novel molecular targets in hepatic stellate cells for the treatment of liver fibrosis
Smith‐Cortinez, N. (2020) · doi:10.33612/diss.128130988 · Cited by 1
Naicker, N. (2014) · ResearchSpace (University of KwaZulu-Natal)
Bioinformatic and molecular study of the regulation of SIRT3 expression
Satterstrom, F. (2015) · Digital Access to Scholarship at Harvard (DASH) (Harvard University)
Upregulation of Renin Angiotensin Aldosterone System (RAAS) by Methylglyoxal: Role in Hypertension
Dhar, I. (2013) · University Library - University of Saskatchewan (University of Saskatchewan)
Thompson, A. C. S. (2014) · ProQuest Demo Repository
Chapter 11 Zyfl amend and Prostate Cancer Therapy
Whelan, J. N., Zhao, Y., Huang, E., MacDonald, A., & Donohoe, D. R. (2016) · Traditional herbal medicines for modern times · doi:10.1201/9781315370156-12
How to Use Type 2 Diabetes Treatments in Clinical Practice: Combination Therapies
Inzucchi, S. E., & Matthews, D. R. (2016) · Wiley eBooks · doi:10.1002/9781118924853.ch33 · Cited by 1
Gillespie, Z. E. (2016) · University Library - University of Saskatchewan (University of Saskatchewan)
Metabolic study of Alzheimer’s disease using mutant C. elegans
Ahmad, W. (2017) · The University of Queensland · doi:10.14264/uql.2017.500
COMPLEX FORMATION EQUILIBRIA OF COPPER(II), METFORMIN AND D-(+)MANNOSE OR D-(+)GLUCOSE IN METHANOL
Márquez-Vargas, A. A., Pérez-Arredondo, M. D. L. L., Vázquez, J. A. R., & Segoviano-Garfias, J. J. N. (2017) · International Journal of Scientific and Research Publications
Callisaya, M. L., & Moran, C. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-809454-9.00012-3
Johnson, V., & Maack, C. (2018) · Der Diabetologe · doi:10.1007/s11428-018-0363-6
Out (2018) · Research Publications (Maastricht University) · doi:10.26481/dis.20180709mo
Antidiabetic properties of centella asiatica in type II diabetic rats.
Oyenihi, A. B. (2016) · ResearchSpace (University of KwaZulu-Natal)
Rahmat, N.-R., Kamalrudin, A., Fazry, S., & Noor, M. M. (2019) · Sains Malaysiana · doi:10.17576/jsm-2019-4801-12
Godoy, A. A. (2019) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.9.2019.tde-09082019-122620
Metformin Toxicity in Acute Kidney Injury. A Rare Cause of Severe Lactic Acidosis
Ajmal, M. S., Vinod, S., & Yan, J. (2019) · doi:10.37421/jnt.2019.9.332
Mechanisms By Which Glucose Lowering Therapies Reduce Obesity And Atherosclerosis
Day, E. A. (2020) · MacSphere (McMaster University) · doi:10.71548/25269
Heart failure in patients with diabetic cardiomyopathy: modern methods of treatment
Zhuravlyova, L., Sokolnikova, N. V., & Rogachova, T. (2020) · Shidnoevropejskij zurnal vnutrisnoi ta simejnoi medicini · doi:10.15407/internalmed2020.01.022
Medicamentos versátiles: buscando balas mágicas
Yamazaki‐Nakashimada, M. A., Rivas‐Larrauri, F., & Rosales-Hernandez, L.-A. (2020) · Revista Latinoamericana de Infectología Pediátrica · doi:10.35366/92384
A Chemical-genetics and Nanoparticle Enabled Approach for in vivo Protein Kinase AnalysisPreprint
Chen, F., Liu, Q., Hilliard, T., Wang, T., Liang, H., Gao, W., Huang, L., & Wang, D. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.05.13.094573
Prevention and Treatment of the Troubles of the Elderly
Libertini, G., Corbi, G., Conti, V., Shubernetskaya, O. S., & Ferrara, N. (2021) · Advances in studies of aging and health · doi:10.1007/978-3-030-73774-0_8
Peng, M., Deng, Y.-L., Yu, L. H., Nie, Y., Luo, T., Huang, J., Zhou, X., & Ding, Y. (2021) · Global Clinical and Translational Research · doi:10.36316/gcatr.03.0043
Chen, C., Gallagher, J. R., Tarlton, J., van Aalten, L., Bray, S. E., Ashford, M. L. J., McCrimmon, R. J., Pearson, E. R., McNeilly, A. D., & Sutherland, C. D. (2021) · PLoS ONE · doi:10.1371/journal.pone.0253533
Self-citationThe gene for the major protein (SVSP109) of bovine semen: structure and promoter analysis.
Bräuer, C., Hanes, J., & Scheit, K. H. (1995) · PubMed
Alvarez, N. T. S., Bautista‐Niño, P. K., Trejos-Suárez, J., & Serrano, N. C. (2021) · Research Square · doi:10.21203/rs.3.rs-1125555/v1
Effects of BTI320 on Glycemic Control in Patients with Type 2 Diabetes
Luke, D. R., Lee, K. K. Y., Kizy, A. E., Sun, D. K., Harris, R., Luke, T. D., & Cheng, C. (2021) · Diabetes & its Complications · doi:10.33425/2639-9326.1096
(2019) · University of Thi-Qar Journal of Science · doi:10.32792/utq/utjsci/vol5/3/10
The Effects of Metformin on Stroke Patients Outcomes: A Literature Review
Triyanti, Y. Z., & Sugianto, P. (2022) · International Journal of Research Publications · doi:10.47119/ijrp1001161120234383
Anti-cancer Efficacy of Metformin: Recent Updates on Breast and Other Cancers
Kabir, M. I., Kumar, R., Bugata, L. S. P., & Raina, K. (2023) · Current Pharmacology Reports · doi:10.1007/s40495-023-00336-w
Inflammation and Diabetes Mellitus
Lim, S., Sarkar, S., & Ahima, R. S. (2023) · Contemporary Endocrinology · doi:10.1007/978-3-031-39721-9_3 · Cited by 1
Al-Hamdy, R. (2015) · University of Thi-Qar Journal of Science · doi:10.32792/utq/utjsci/v5i3.142
Reducing the Effects of the Tumor on the Brain
Mravec, B. (2024) · Springer eBooks · doi:10.1007/978-3-031-68590-3_58
Type 2 Diabetes Mellitus in Youth
Srinivasan, S., & Levitsky, L. L. (2024) · Springer eBooks · doi:10.1007/978-3-031-66296-6_31
Effectiveness of Moringa Oleifera Extract in Type II Diabetes: A Comprehensive Literature Review
Ahmed, S., Regmi, P., & Pandey, S. (2024) · medtigo Journal of Medicine · doi:10.63096/medtigo3061121 · Cited by 2
Islam, M. T., Akbor, M. S., Sheikh, S., Ferdous, J., Chowdhury, R., Bhuia, M. S., Ansari, I. A., Ansari, S. A., Saleh, N. A. I., de Farias, P. A. M., et al. (2025) · Pharmacological Research - Natural Products · doi:10.1016/j.prenap.2025.100241
Bishnu, A., Taylor, R. W., Sakamoto, K., & Ganley, I. G. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2025.12.03.692069
Self-citationYu, D.-Q., Xu, G.-X., Teng, X.-Y., Xu, J.-W., Tang, L.-F., Feng, C., Rao, J.-P., Jin, M., & Wang, L.-Q. (2021) · Figshare · doi:10.6084/m9.figshare.16800535
Yu, D.-Q., Xu, G.-X., Teng, X.-Y., Xu, J.-W., Tang, L.-F., Feng, C., Rao, J.-P., Jin, M., & Wang, L.-Q. (2021) · Figshare · doi:10.6084/m9.figshare.16800514
Yu, D.-Q., Xu, G.-X., Teng, X.-Y., Xu, J.-W., Tang, L.-F., Feng, C., Rao, J.-P., Jin, M., & Wang, L.-Q. (2021) · Figshare · doi:10.6084/m9.figshare.16800502
Ahmed, A. R., Korany, M. A., Galal, S. M., & Ragab, M. A. A. (2023) · Figshare · doi:10.6084/m9.figshare.23740760
Yu, D.-Q., Xu, G.-X., Teng, X.-Y., Xu, J.-W., Tang, L.-F., Feng, C., Rao, J.-P., Jin, M., & Wang, L.-Q. (2021) · Figshare · doi:10.6084/m9.figshare.16800520
Yu, D.-Q., Xu, G.-X., Teng, X.-Y., Xu, J.-W., Tang, L.-F., Feng, C., Rao, J.-P., Jin, M., & Wang, L.-Q. (2021) · Figshare · doi:10.6084/m9.figshare.16800505
Yu, D.-Q., Xu, G.-X., Teng, X.-Y., Xu, J.-W., Tang, L.-F., Feng, C., Rao, J.-P., Jin, M., & Wang, L.-Q. (2021) · Figshare · doi:10.6084/m9.figshare.16800532
Yu, D.-Q., Xu, G.-X., Teng, X.-Y., Xu, J.-W., Tang, L.-F., Feng, C., Rao, J.-P., Jin, M., & Wang, L.-Q. (2021) · Figshare · doi:10.6084/m9.figshare.16800517
Yu, D.-Q., Xu, G.-X., Teng, X.-Y., Xu, J.-W., Tang, L.-F., Feng, C., Rao, J.-P., Jin, M., & Wang, L.-Q. (2021) · Figshare · doi:10.6084/m9.figshare.16800529
Yu, D.-Q., Xu, G.-X., Teng, X.-Y., Xu, J.-W., Tang, L.-F., Feng, C., Rao, J.-P., Jin, M., & Wang, L.-Q. (2021) · Figshare · doi:10.6084/m9.figshare.16800523
Yu, D.-Q., Xu, G.-X., Teng, X.-Y., Xu, J.-W., Tang, L.-F., Feng, C., Rao, J.-P., Jin, M., & Wang, L.-Q. (2021) · Figshare · doi:10.6084/m9.figshare.16800526
Yu, D.-Q., Xu, G.-X., Teng, X.-Y., Xu, J.-W., Tang, L.-F., Feng, C., Rao, J.-P., Jin, M., & Wang, L.-Q. (2021) · Figshare · doi:10.6084/m9.figshare.16800538
Yu, D.-Q., Xu, G.-X., Teng, X.-Y., Xu, J.-W., Tang, L.-F., Feng, C., Rao, J.-P., Jin, M., & Wang, L.-Q. (2021) · Figshare · doi:10.6084/m9.figshare.16800508
Yu, D.-Q., Xu, G.-X., Teng, X.-Y., Xu, J.-W., Tang, L.-F., Feng, C., Rao, J.-P., Jin, M., & Wang, L.-Q. (2021) · Figshare · doi:10.6084/m9.figshare.16800499
Yu, D.-Q., Xu, G.-X., Teng, X.-Y., Xu, J.-W., Tang, L.-F., Feng, C., Rao, J.-P., Jin, M., & Wang, L.-Q. (2021) · Figshare · doi:10.6084/m9.figshare.16800496
Yu, D.-Q., Xu, G.-X., Teng, X.-Y., Xu, J.-W., Tang, L.-F., Feng, C., Rao, J.-P., Jin, M., & Wang, L.-Q. (2021) · Figshare · doi:10.6084/m9.figshare.16800511
Dias-Lopes, G., dos Anjos, L. R., da Cruz, S. M. X., Abrão, C. D., Gonçalves, M. E. P., Souza‐Silva, F., Fabišíková, A., Pérez, E. R., & Alves, C. R. (2026) · Molecules · doi:10.3390/molecules31040629
Huang, Z., Hu, X., Liu, Z. P., Rao, L., Ren, Y., Li, W., Cao, H., Yang, R., Zhao, D., Chu, Y., et al. (2026) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.5c03569
Bang, Y., Lee, S., Gal, J., & Choi, H. J. (2026) · Drug Targets and Therapeutics · doi:10.58502/dtt.25.0020
Metformin & Chronic Kidney Disease (CKD) : a reassessment of the benefit/risk ratio
Kajbaf, F. (2015) · theses.fr (ABES) · doi:10.70675/7a26b581z94ddz4e2fz9a48z97f6f7d8354a
Ge, X., Luo, Z., Zhang, Y., Zhang, L., Wang, G., Yuan, X., Li, Q., & Zhai, X. (2026) · Frontiers in Neuroscience · doi:10.3389/fnins.2026.1744208
Vangala, S., Murthati, K., & Banerjee, R. (2026) · Discover Chemistry. · doi:10.1007/s44371-026-00668-8
Murtaza, S., Murtaza, F., Yasin, M. U., Shahid, A. A., Shahid, M., Rehan, M., Ata, F., Asghar, M. S., & Eljack, M. M. F. (2026) · Endocrinology Diabetes & Metabolism · doi:10.1002/edm2.70235
Lac-Phe: An Exercise Hormone for Metabolic Regulation
Liu, Q., & Xu, Y. (2026) · Annual Review of Nutrition · doi:10.1146/annurev-nutr-061824-054717
Metadata
- Authors
- Rena, G., Pearson, E. R., & Sakamoto, K.
- Affiliations
- University of Dundee (GB)
- École Polytechnique Fédérale de Lausanne (CH)
- Corresponding author
- Rena, Graham
- Sakamoto, Kei
- Venue
- Diabetologia
- Published
- 2013-07-09
- Volume
- 56
- Issue
- 9
- Pages
- 1898-1906
- ISSN
- 0012-186X (ISSN-L)
- 1432-0428
- PMC
- PMC3737434
- OpenAlex
- W2025130292
- Cited by
- 479
- References
- 98
- Citations by year
- 2026: 9 · 2025: 22 · 2024: 20 · 2023: 33 · 2022: 22 · 2021: 52 · 2020: 33 · 2019: 38 · 2018: 58 · 2017: 51 · 2016: 37 · 2015: 52 · 2014: 43 · 2013: 8
- FWCI
- 4.39
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Diabetologia (publishedVersion, cc-by-nc)
- Europe PMC (PubMed Central) (publishedVersion, cc-by-nc)
- PubMed Central (publishedVersion, cc-by-nc)
- PubMed (publishedVersion)
- reroDoc Digital Library (submittedVersion)
- Discovery Research Portal (University of Dundee) (submittedVersion)
- Funders
- Medical Research Council (MR/K012924/1)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolism, Diabetes, and Cancer
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Natural Antidiabetic Agents Studies
- Keywords
- metformin, molecular mechanisms of action, type 2 diabetes, AMPK, glucagon, therapeutic target
- MeSH terms
- Diabetes Mellitus, Type 2, Energy Metabolism, Gluconeogenesis, Humans, Metformin, Models, Biological, AMP-Activated Protein Kinases
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review